세이프티 란셋 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of safety lancets Market

The global safety lancets market was valued at USD 1.21 billion in 2025 and is projected to grow to USD 1.34 billion in 2026, reaching USD 3.28 billion by 2034, registering a robust CAGR of 11.81% during the forecast period. Safety lancets are specialized medical devices designed for blood sampling, primarily used for diabetes management and other diagnostic applications. These devices incorporate safety features to minimize accidental needle-stick injuries, enhancing protection for both healthcare providers and patients.

The growing prevalence of diabetes and other chronic diseases, along with technological innovations and regulatory pressures promoting safer medical practices, are key factors driving market growth. North America led the market in 2025, accounting for 37.74% of the global share, due to the high incidence of diabetes and significant reimbursement programs for blood glucose monitoring products.

Market Dynamics

Drivers: The increasing incidence of diabetes is a major driver of the safety lancets market. According to the Institute for Health Metrics and Evaluation (2023), over half a billion individuals globally are living with diabetes. The rising preference for home monitoring solutions, convenience, and less invasive blood sampling methods further propel demand. Patients increasingly seek comfort and compliance in regular testing routines, making safety lancets essential tools for effective disease management.

Restraints: High cost remains a challenge, especially in developing regions. Safety lancets typically cost USD 4.87-5.06 per 100 lancets, compared to USD 2.37-4.22 for traditional lancets, limiting adoption among price-sensitive healthcare providers and patients.

Opportunities: The growing trend of home healthcare monitoring presents significant opportunities. Self-monitoring of blood glucose (SMBG) is increasing globally; a 2023 study in the Indian Journal of Medical Specialties reported that 35% of patients used glucometers for SMBG at home. Safety lancets are well-suited for home use due to ease of use and reduced risk of needle-stick injuries.

Challenges: Limited healthcare spending in developing countries restricts market growth. Low public healthcare budgets, such as Bangladesh's 2.34% GDP expenditure on healthcare, hinder the availability and adoption of advanced devices.

Market Trends

A key trend is the shift toward automatic/pressure-activated safety lancets, favored for their automatic needle retraction and reduced risk of injury. Studies indicate that automatic lancets cause less pain and improve efficiency in both clinical and home care settings.

Segmentation Analysis

By Type:

• Button-activated lancets dominate, holding 62.57% market share in 2026, due to ease of use and simple activation mechanisms.
• Pressure/contact-activated lancets offer consistent puncture depth and enhanced safety, with increasing adoption in developed regions.

By Incision Type:

• Needle lancets dominate due to safety features and reduced pain.
• Blade lancets are growing, especially for neonatal screening and dried blood spot tests, providing higher blood volumes for certain diagnostics.

By Age Group:

• Adults dominate due to frequent blood glucose, HbA1c, and cholesterol testing.
• Pediatrics are witnessing growth due to type 1 diabetes monitoring and SMBG recommendations.

By Application:

• Blood glucose monitoring leads with 59.67% market share in 2026, driven by diabetes prevalence.
• Hemoglobin testing is projected for the fastest growth, while cholesterol testing shows moderate adoption.
• Other applications include lipid profiling, coagulation monitoring, and dried blood spot tests.

By End-user:

• Hospitals & clinics lead with 41.40% market share in 2026 due to patient visits and assisted monitoring programs.
• Home care is expected to achieve the highest CAGR due to SMBG adoption.
• Others include blood banks, diagnostic labs, academic institutions, and nursing homes.

Regional Outlook

• North America: Market value of USD 0.46 billion in 2025, reaching USD 0.51 billion in 2026, driven by high diabetes prevalence and strong reimbursement policies.
• Europe: Key markets include the U.K. (USD 0.03 billion in 2026) and Germany (USD 0.10 billion in 2026) due to advanced healthcare infrastructure.
• Asia Pacific: Projected highest CAGR with Japan (USD 0.04 billion), China (USD 0.15 billion), and India (USD 0.08 billion) in 2026, supported by domestic manufacturers and large diabetic populations.
• Latin America: Growth due to rising healthcare expenditure and home monitoring demand.
• Middle East & Africa: Steady growth attributed to diabetes awareness and favorable policies.

Competitive Landscape

The market is highly fragmented, with major players such as BD, HTL-STREFA, Abbott, Cardinal Health, B. Braun SE, Terumo Medical Corporation, SARSTEDT AG & Co. KG, and YPSOMED focusing on product innovation, geographic expansion, and distribution partnerships. Key industry developments include product launches, national agreements, and participation in global medical exhibitions.

Conclusion

The global safety lancets market is poised for substantial growth, from USD 1.21 billion in 2025 to USD 3.28 billion by 2034, driven by rising diabetes prevalence, home monitoring adoption, and technological advancements in lancet safety. North America remains the dominant market, while Asia Pacific offers the highest growth potential. Although high costs and limited healthcare spending in some regions present challenges, the increasing focus on patient safety and convenient monitoring solutions positions the market for sustained expansion. Key players with strong R&D and distribution networks are expected to consolidate their leadership, shaping the competitive landscape in the coming years.

Segmentation By Type

• Button-activated
• Pressure/Contact-activated

By Incision Type

• Needle
• Blade

By Age Group

• Adult
• Pediatric

By Application

• Blood Glucose Monitoring
• Hemoglobin Testing
• Cholesterol Testing
• Others

By End-user

• Hospitals & Clinics
• Home Care
• Others

By Region

• North America (By Type, Incision Type, Age Group, Application, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2025
• 4.2. Number of SMBG User, By Key Countries/Region, 2025
• 4.3. Advancements in Safety Lancets
• 4.4. Overview: Reimbursement Scenario
• 4.5. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)

5. Global Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Button-activated
  • 5.1.2. Pressure/Contact-activated
• 5.2. Market Analysis, Insights and Forecast - By Incision Type
  • 5.2.1. Needle
  • 5.2.2. Blade
• 5.3. Market Analysis, Insights and Forecast - By Age Group
  • 5.3.1. Adult
  • 5.3.2. Pediatric
• 5.4. Market Analysis, Insights and Forecast - By Application
  • 5.4.1. Blood Glucose Monitoring
  • 5.4.2. Hemoglobin Testing
  • 5.4.3. Cholesterol Testing
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By End-user
  • 5.5.1. Hospitals & Clinics
  • 5.5.2. Home Care
  • 5.5.3. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Button-activated
  • 6.1.2. Pressure/Contact-activated
• 6.2. Market Analysis, Insights and Forecast - By Incision Type
  • 6.2.1. Needle
  • 6.2.2. Blade
• 6.3. Market Analysis, Insights and Forecast - By Age Group
  • 6.3.1. Adult
  • 6.3.2. Pediatric
• 6.4. Market Analysis, Insights and Forecast - By Application
  • 6.4.1. Blood Glucose Monitoring
  • 6.4.2. Hemoglobin Testing
  • 6.4.3. Cholesterol Testing
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By End-user
  • 6.5.1. Hospitals & Clinics
  • 6.5.2. Home Care
  • 6.5.3. Others
• 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Button-activated
  • 7.1.2. Pressure/Contact-activated
• 7.2. Market Analysis, Insights and Forecast - By Incision Type
  • 7.2.1. Needle
  • 7.2.2. Blade
• 7.3. Market Analysis, Insights and Forecast - By Age Group
  • 7.3.1. Adult
  • 7.3.2. Pediatric
• 7.4. Market Analysis, Insights and Forecast - By Application
  • 7.4.1. Blood Glucose Monitoring
  • 7.4.2. Hemoglobin Testing
  • 7.4.3. Cholesterol Testing
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By End-user
  • 7.5.1. Hospitals & Clinics
  • 7.5.2. Home Care
  • 7.5.3. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. Germany
  • 7.6.2. U.K.
  • 7.6.3. France
  • 7.6.4. Italy
  • 7.6.5. Spain
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia pacific Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Button-activated
  • 8.1.2. Pressure/Contact-activated
• 8.2. Market Analysis, Insights and Forecast - By Incision Type
  • 8.2.1. Needle
  • 8.2.2. Blade
• 8.3. Market Analysis, Insights and Forecast - By Age Group
  • 8.3.1. Adult
  • 8.3.2. Pediatric
• 8.4. Market Analysis, Insights and Forecast - By Application
  • 8.4.1. Blood Glucose Monitoring
  • 8.4.2. Hemoglobin Testing
  • 8.4.3. Cholesterol Testing
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By End-user
  • 8.5.1. Hospitals & Clinics
  • 8.5.2. Home Care
  • 8.5.3. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. Southeast Asia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Button-activated
  • 9.1.2. Pressure/Contact-activated
• 9.2. Market Analysis, Insights and Forecast - By Incision Type
  • 9.2.1. Needle
  • 9.2.2. Blade
• 9.3. Market Analysis, Insights and Forecast - By Age Group
  • 9.3.1. Adult
  • 9.3.2. Pediatric
• 9.4. Market Analysis, Insights and Forecast - By Application
  • 9.4.1. Blood Glucose Monitoring
  • 9.4.2. Hemoglobin Testing
  • 9.4.3. Cholesterol Testing
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By End-user
  • 9.5.1. Hospitals & Clinics
  • 9.5.2. Home Care
  • 9.5.3. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Button-activated
  • 10.1.2. Pressure/Contact-activated
• 10.2. Market Analysis, Insights and Forecast - By Incision Type
  • 10.2.1. Needle
  • 10.2.2. Blade
• 10.3. Market Analysis, Insights and Forecast - By Age Group
  • 10.3.1. Adult
  • 10.3.2. Pediatric
• 10.4. Market Analysis, Insights and Forecast - By Application
  • 10.4.1. Blood Glucose Monitoring
  • 10.4.2. Hemoglobin Testing
  • 10.4.3. Cholesterol Testing
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By End-user
  • 10.5.1. Hospitals & Clinics
  • 10.5.2. Home Care
  • 10.5.3. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. GCC
  • 10.6.2. South Africa
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. BD
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. SARSTEDT AG & Co. KG
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Greiner Bio-One International GmbH
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Terumo Medical Corporation
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. B. Braun SE
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Abbott
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Cardinal Health
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. YPSOMED
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Biosense Technologies Private Limited
    • 11.2.10.1. Overview
    • 11.2.10.2. Products
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)